Insider Trading activities of Jazz Pharmaceuticals Plc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jazz Pharmaceuticals Plc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jazz Pharmaceuticals Plc since year 2005. Table 2 shows the detailed insider transactions of Jazz Pharmaceuticals Plc since 2005. The reporting company's ticker symbol is JAZZ. The reporting company's CIK number is 1232524.
The total value of stock buying since 2005 is $10,920,190.
The total value of stock sales since 2005 is $1,490,659,918.
The total value of stock option exercises since 2005 is $45,575,568.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Jazz Pharmaceuticals Plc (JAZZ).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-10 0 $0 2,200 $360,737 0 $0
2018-09 0 $0 12,330 $2,070,925 10,130 $1,408,677
2018-08 0 $0 26,625 $4,688,157 9,000 $578,655
2018-07 0 $0 2,500 $432,368 0 $0
2018-06 0 $0 12,900 $2,192,444 5,000 $293,600
2018-05 0 $0 6,380 $1,038,705 0 $0
2018-04 0 $0 5,799 $895,060 0 $0
2018-03 0 $0 4,523 $656,772 0 $0
2018-02 0 $0 3,335 $488,146 0 $0
2018-01 0 $0 3,900 $586,242 0 $0
2017-12 0 $0 9,200 $1,282,439 59,758 $2,510,656
2017-11 0 $0 8,352 $1,114,242 8,000 $374,640
2017-10 0 $0 1,000 $150,000 0 $0
2017-09 0 $0 1,000 $153,520 0 $0
2017-08 0 $0 8,460 $1,214,491 0 $0
2017-07 0 $0 4,780 $763,794 0 $0
2017-06 0 $0 5,620 $847,330 0 $0
2017-05 0 $0 32,500 $5,002,660 0 $0
2017-04 0 $0 16,433 $2,530,997 11,458 $607,044
2017-03 0 $0 1,084 $144,242 3,646 $193,165
2017-01 0 $0 4,200 $533,186 0 $0
2016-12 0 $0 2,231 $227,372 0 $0
2016-11 2,000 $227,698 200 $22,438 0 $0
2016-10 0 $0 200 $23,632 0 $0
2016-09 0 $0 200 $25,234 0 $0
2016-08 608 $83,406 38,210 $5,046,293 0 $0
2016-07 580 $83,304 100 $14,243 0 $0
2016-06 557 $83,334 100 $14,963 0 $0
2016-05 0 $0 29,409 $4,408,038 0 $0
2016-04 0 $0 11,872 $1,714,673 0 $0
2016-03 0 $0 2,600 $328,016 0 $0
2016-02 0 $0 27,968 $3,435,197 0 $0
2016-01 0 $0 12,600 $1,706,170 0 $0
2015-12 0 $0 13,024 $1,894,258 0 $0
2015-11 0 $0 43,389 $6,157,369 0 $0
2015-10 0 $0 14,600 $1,941,362 0 $0
2015-09 0 $0 12,600 $2,086,669 0 $0
2015-08 0 $0 25,148 $4,531,363 0 $0
2015-07 0 $0 19,000 $3,372,600 4,000 $187,320
2015-06 0 $0 24,751 $4,378,249 9,494 $478,392
2015-05 0 $0 28,906 $5,093,309 13,907 $696,368
2015-04 0 $0 19,500 $3,415,505 0 $0
2015-03 0 $0 119,949 $21,529,315 7,010 $278,313
2015-02 0 $0 21,851 $3,651,626 6,851 $320,832
2015-01 0 $0 16,851 $2,714,612 1,851 $86,682
2014-12 0 $0 69,195 $11,559,024 1,347 $63,080
2014-11 0 $0 37,112 $6,365,532 13,333 $702,279
2014-10 0 $0 17,852 $2,742,792 667 $31,235
2014-09 0 $0 123,352 $20,822,680 6,167 $182,265
2014-08 0 $0 16,777 $2,256,292 5,600 $292,585
2014-07 0 $0 11,344 $1,783,320 4,822 $177,388
2014-06 0 $0 63,750 $9,558,022 3,000 $158,940
2014-05 0 $0 8,061 $1,059,773 667 $31,235
2014-04 0 $0 36,917 $5,042,400 3,667 $190,175
2014-03 0 $0 573,289 $89,505,584 6,000 $336,330
2014-02 0 $0 595,677 $95,723,862 24,014 $721,720
2014-01 0 $0 2,000 $263,640 0 $0
2013-12 0 $0 4,325 $517,585 1,325 $62,049
2013-11 0 $0 5,373 $536,380 2,373 $111,127
2013-10 0 $0 12,000 $1,018,219 5,000 $234,150
2013-09 0 $0 14,000 $1,224,220 5,000 $234,150
2013-08 0 $0 294,298 $23,936,221 7,500 $351,225
2013-07 0 $0 8,000 $583,700 0 $0
2013-06 0 $0 5,000 $341,650 1,452 $16,668
2013-05 0 $0 7,000 $412,620 0 $0
2013-04 0 $0 4,000 $218,080 0 $0
2013-03 0 $0 9,134,008 $532,341,172 92,698 $1,229,515
2013-02 0 $0 70,650 $4,110,678 0 $0
2013-01 0 $0 70,650 $3,994,335 0 $0
2012-12 0 $0 4,000 $202,200 0 $0
2012-11 0 $0 4,000 $204,440 0 $0
2012-10 0 $0 75,650 $4,442,977 0 $0
2012-08 0 $0 260,000 $11,915,500 0 $0
2012-03 0 $0 10,883,366 $539,379,618 0 $0
2012-01 0 $0 114,605 $4,989,328 1,710,855 $31,587,142
2011-12 0 $0 0 $0 46,536 $624,513
2011-11 3,000 $112,080 0 $0 0 $0
2011-08 0 $0 107,928 $3,890,048 1,399 $0
2011-07 0 $0 32,384 $1,310,580 0 $0
2010-12 0 $0 85,000 $1,547,235 25,000 $115,125
2010-11 0 $0 102,792 $1,568,909 86,663 $108,328
2010-09 6,000 $58,560 0 $0 0 $0
2010-08 60,000 $522,224 0 $0 0 $0
2010-05 838,323 $6,999,997 0 $0 0 $0
2010-03 0 $0 29,467 $337,657 0 $0
2009-12 0 $0 5,500 $41,173 0 $0
2009-11 9,788 $66,998 0 $0 0 $0
2009-09 150,000 $1,082,383 3,500 $32,861 0 $0
2009-08 0 $0 93 $648 0 $0
2008-07 4,982,909 $0 0 $0 0 $0
2008-04 129,796 $1,126,173 0 $0 0 $0
2008-03 3 $27 0 $0 0 $0
2007-11 28,638 $383,839 0 $0 0 $0
2007-06 5,212 $90,167 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Jazz Pharmaceuticals Plc insiders (JAZZ)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-10-15 Young Matthew P. (EVP & CFO) Sale 700 158.08 110,658
2018-10-12 Miller Michael Patrick (EVP, US Commercial) Sale 200 158.46 31,692
2018-10-01 Cozadd Bruce C (Chairman & CEO) Sale 1,300 167.99 218,387
2018-09-21 Cozadd Bruce C (Chairman & CEO) Sale 1,300 164.36 213,668
2018-09-17 Young Matthew P. (EVP & CFO) Sale 700 162.70 113,889
2018-09-14 Miller Michael Patrick (EVP, US Commercial) Sale 200 165.20 33,040
2018-09-06 Enright Patrick G (Director) Sale 10,130 168.84 1,710,328
2018-09-06 Enright Patrick G (Director) Option Ex 10,130 139.06 1,408,677
2018-08-15 Young Matthew P. (EVP & CFO) Sale 700 176.05 123,235
2018-08-14 Miller Michael Patrick (EVP, US Commercial) Sale 200 175.70 35,140
2018-08-10 Treacy Paul (SVP, Technical Operations) Sale 1,309 176.61 231,183
2018-08-10 Schnee Elmar (Director) Sale 742 176.61 131,044
2018-08-10 Gray Peter (Director) Sale 715 176.61 126,276
2018-08-10 Mcsharry Heather Ann (Director) Sale 715 176.61 126,276
2018-08-10 Sohn Catherine A. (Director) Sale 660 176.61 116,563
2018-08-10 O'keefe Kenneth W (Director) Sale 660 176.61 116,563
2018-08-10 Winningham Rick E (Director) Sale 660 176.61 116,563
2018-08-10 Enright Patrick G (Director) Sale 1,365 175.13 239,056
2018-08-10 Berns Paul L (Director) Sale 660 176.61 116,563
2018-08-10 Riedel Norbert G (Director) Sale 660 176.61 116,563
2018-08-09 Winningham Rick E (Director) Sale 15,979 176.16 2,814,892
2018-08-09 Winningham Rick E (Director) Option Ex 9,000 64.30 578,655
2018-08-01 Cozadd Bruce C (Chairman & CEO) Sale 1,600 173.90 278,240
2018-07-16 Young Matthew P. (EVP & CFO) Sale 700 176.06 123,242
2018-07-13 Miller Michael Patrick (EVP, US Commercial) Sale 200 179.15 35,830
2018-07-02 Cozadd Bruce C (Chairman & CEO) Sale 1,600 170.81 273,296
2018-06-15 Young Matthew P. (EVP & CFO) Sale 700 176.99 123,893
2018-06-14 Miller Michael Patrick (EVP, US Commercial) Sale 200 176.53 35,306
2018-06-01 Young Matthew P. (EVP & CFO) Sale 5,000 170.04 850,210
2018-06-01 Young Matthew P. (EVP & CFO) Option Ex 5,000 58.72 293,600
2018-06-01 Cozadd Bruce C (Chairman & CEO) Sale 7,000 169.00 1,183,035
2018-05-15 Young Matthew P. (EVP & CFO) Sale 1,420 164.64 233,788
2018-05-14 Miller Michael Patrick (EVP, US Commercial) Sale 200 164.68 32,936
2018-05-11 Wilson Karen J (SVP, Finance & PAO) Sale 3,760 165.00 620,411
2018-05-01 Cozadd Bruce C (Chairman & CEO) Sale 1,000 151.57 151,570
2018-04-16 Young Matthew P. (EVP & CFO) Sale 700 156.01 109,207
2018-04-13 Miller Michael Patrick (EVP, US Commercial) Sale 200 157.49 31,498
2018-04-10 Wilson Karen J (SVP, Finance & PAO) Sale 3,899 155.00 604,345
2018-04-02 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.01 150,010
2018-03-15 Young Matthew P. (EVP & CFO) Sale 700 151.22 105,854
2018-03-14 Miller Michael Patrick (EVP, US Commercial) Sale 200 151.12 30,224
2018-03-09 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.00 150,000
2018-03-06 Treacy Paul (SVP, Technical Operations) Sale 594 141.47 84,030
2018-03-06 Young Matthew P. (EVP & CFO) Sale 1,152 142.55 164,217
2018-03-02 Treacy Paul (SVP, Technical Operations) Sale 877 139.62 122,447
2018-02-28 Young Matthew P. (EVP & CFO) Sale 1,219 147.95 180,355
2018-02-27 Young Matthew P. (EVP & CFO) Sale 1,916 146.03 279,793
2018-02-14 Miller Michael Patrick (EVP, US Commercial) Sale 200 139.99 27,998
2018-01-16 Young Matthew P. (EVP & CFO) Sale 700 152.16 106,512
2018-01-12 Miller Michael Patrick (EVP, US Commercial) Sale 200 148.65 29,730
2018-01-12 Cozadd Bruce C (Chairman & CEO) Sale 3,000 150.00 450,000
2017-12-11 Cox Russell J. (EVP & COO) Option Ex 50,758 38.06 1,932,001
2017-12-11 Enright Patrick G (Director) Sale 9,000 139.40 1,254,609
2017-12-11 Enright Patrick G (Director) Option Ex 9,000 64.30 578,655
2017-12-11 Miller Michael Patrick (EVP, US Commercial) Sale 200 139.15 27,830
2017-11-17 Mcgill Iain (SVP, Europe & Rest of World) Sale 8,000 133.42 1,067,360
2017-11-17 Mcgill Iain (SVP, Europe & Rest of World) Option Ex 8,000 46.83 374,640
2017-11-17 Enright Patrick G (Director) Sale 352 133.19 46,882
2017-10-02 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.00 150,000
2017-09-12 Cozadd Bruce C (Chairman & CEO) Sale 1,000 153.52 153,520
2017-08-25 Enright Patrick G (Director) Sale 351 148.40 52,088
2017-08-15 Miller Michael Patrick (EVP, US Commercial) Sale 200 144.38 28,876
2017-08-14 Treacy Paul (SVP, Technical Operations) Sale 1,304 143.35 186,932
2017-08-11 Schnee Elmar (Director) Sale 1,199 143.56 172,132
2017-08-11 Gray Peter (Director) Sale 717 143.29 102,738
2017-08-11 Mcsharry Heather Ann (Director) Sale 717 143.24 102,705
2017-08-11 Sohn Catherine A. (Director) Sale 662 143.29 94,857
2017-08-11 O'keefe Kenneth W (Director) Sale 662 143.24 94,822
2017-08-11 Winningham Rick E (Director) Sale 662 143.29 94,857
2017-08-11 Enright Patrick G (Director) Sale 662 143.25 94,828
2017-08-11 Berns Paul L (Director) Sale 662 143.25 94,828
2017-08-11 Riedel Norbert G (Director) Sale 662 143.25 94,828
2017-07-20 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 4,580 160.00 732,800
2017-07-17 Miller Michael Patrick (EVP, US Commercial) Sale 200 154.97 30,994
2017-06-23 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 420 160.00 67,200
2017-06-15 Miller Michael Patrick (EVP, US Commercial) Sale 200 150.65 30,130
2017-06-01 Winningham Rick E (Director) Sale 5,000 150.00 750,000
2017-05-11 Cozadd Bruce C (Chairman & CEO) Sale 30,000 153.42 4,602,660
2017-05-09 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,500 160.00 400,000
2017-04-27 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,500 160.00 400,000
2017-04-27 Wilson Karen J (SVP, Finance & PAO) Sale 1,275 160.00 204,000
2017-04-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 152.56 30,512
2017-04-11 Cozadd Bruce C (Chairman & CEO) Sale 1,000 152.12 152,120
2017-04-10 Wilson Karen J (SVP, Finance & PAO) Sale 11,458 152.24 1,744,365
2017-04-10 Wilson Karen J (SVP, Finance & PAO) Option Ex 11,458 52.98 607,044
2017-03-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 137.89 27,577
2017-03-08 Wilson Karen J (SVP, Finance & PAO) Option Ex 3,646 52.98 193,165
2017-03-06 Treacy Paul (SVP, Technical Operations) Sale 884 131.97 116,665
2017-01-18 Cox Russell J. (EVP & COO) Sale 4,000 127.50 510,000
2017-01-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 115.93 23,186
2016-12-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 103.09 20,618
2016-12-02 Enright Patrick G (Director) Sale 1,354 101.80 137,836
2016-11-15 Miller Michael Patrick (SVP, US Commercial) Sale 200 112.19 22,438
2016-11-14 O'keefe Kenneth W (Director) Buy 500 112.45 56,223
2016-11-11 O'keefe Kenneth W (Director) Buy 1,500 114.32 171,475
2016-10-17 Miller Michael Patrick (SVP, US Commercial) Sale 200 118.16 23,632
2016-09-19 Miller Michael Patrick (SVP, US Commercial) Sale 200 126.17 25,234
2016-08-25 Mulligan Seamus (Director) Sale 27,968 128.19 3,585,078
2016-08-16 Treacy Paul (SVP, Technical Operations) Sale 1,292 137.46 177,603
2016-08-15 Mcsharry Heather Ann (Director) Sale 685 136.45 93,468
2016-08-15 Sohn Catherine A. (Director) Sale 633 136.45 86,372
2016-08-15 Winningham Rick E (Director) Sale 633 136.45 86,372
2016-08-15 Enright Patrick G (Director) Sale 633 136.45 86,372
2016-08-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 136.45 13,644
2016-08-15 Berns Paul L (Director) Sale 633 136.45 86,372
2016-08-15 Riedel Norbert G (Director) Sale 633 136.45 86,372
2016-08-12 Smith Karen L. (Global Head of R&D and CMO) Buy 608 137.18 83,406
2016-08-09 Cox Russell J. (EVP & COO) Sale 4,000 148.66 594,640
2016-08-09 Cozadd Bruce C (Chairman & CEO) Sale 1,000 150.00 150,000
2016-07-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 142.43 14,243
2016-07-13 Smith Karen L. (Global Head of R&D and CMO) Buy 580 143.63 83,304
2016-06-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 149.64 14,963
2016-06-13 Smith Karen L. (Global Head of R&D and CMO) Buy 557 149.61 83,334
2016-05-24 Mulligan Seamus (Director) Sale 27,968 150.13 4,198,807
2016-05-16 Mcsharry Heather Ann (Director) Sale 697 145.20 101,204
2016-05-16 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.20 14,519
2016-05-16 Riedel Norbert G (Director) Sale 644 145.20 93,508
2016-04-25 Wilson Karen J (SVP, Finance & PAO) Sale 604 160.00 96,640
2016-04-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.79 14,579
2016-04-13 Wilson Karen J (SVP, Finance & PAO) Sale 5,007 150.00 751,050
2016-04-12 Cox Russell J. (EVP & COO) Sale 4,000 136.98 547,920
2016-04-07 Wilson Karen J (SVP, Finance & PAO) Sale 2,161 140.90 304,484
2016-03-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 129.17 12,916
2016-03-08 Cozadd Bruce C (Chairman & CEO) Sale 2,500 126.04 315,100
2016-02-23 Mulligan Seamus (Director) Sale 27,968 122.83 3,435,197
2016-01-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 122.66 12,266
2016-01-12 Cozadd Bruce C (Chairman & CEO) Sale 2,500 123.81 309,525
2016-01-05 Enright Patrick G (Director) Sale 10,000 138.44 1,384,379
2015-12-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 136.99 13,699
2015-12-08 Cozadd Bruce C (Chairman & CEO) Sale 2,500 139.72 349,300
2015-12-02 Enright Patrick G (Director) Sale 424 148.49 62,959
2015-12-01 Enright Patrick G (Director) Sale 10,000 146.83 1,468,300
2015-11-23 Mulligan Seamus (Director) Sale 10,243 147.65 1,512,419
2015-11-20 Mulligan Seamus (Director) Sale 17,725 145.70 2,582,567
2015-11-16 Miller Michael Patrick (SVP, US Commercial) Sale 100 134.03 13,403
2015-11-13 Mcgill Iain (SVP, Europe & Rest of World) Sale 2,821 135.73 382,885
2015-11-10 Enright Patrick G (Director) Sale 10,000 134.48 1,344,770
2015-11-10 Cozadd Bruce C (Chairman & CEO) Sale 2,500 128.53 321,325
2015-10-21 Hooper Suzanne Sawochka (EVP & General Counsel) Sale 2,000 125.00 250,006
2015-10-15 Miller Michael Patrick (SVP, US Commercial) Sale 100 131.86 13,186
2015-10-13 Cozadd Bruce C (Chairman and CEO) Sale 2,500 131.50 328,750
2015-10-05 Enright Patrick G (Director) Sale 10,000 134.94 1,349,420
2015-09-25 Miller Michael Patrick (SVP, US Commercial) Sale 100 145.23 14,522
2015-09-08 Cozadd Bruce C (Chairman and CEO) Sale 2,500 163.44 408,587
2015-09-01 Enright Patrick G (Director) Sale 10,000 166.36 1,663,560
2015-08-27 Enright Patrick G (Director) Sale 425 167.87 71,344
2015-08-11 Treacy Paul (SVP, Technical Operations) Sale 1,330 177.67 236,295
2015-08-11 Sohn Catherine A. (Director) Sale 654 177.77 116,258
2015-08-11 Hooper Suzanne Sawochka (EVP and General Counsel) Sale 4,000 177.82 711,280
2015-08-11 Cox Russell J. (EVP & Chief Commercial Officer) Sale 500 177.82 88,910
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of JAZZ listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jazz Pharmaceuticals Plc (symbol JAZZ, CIK number 1232524) see the Securities and Exchange Commission (SEC) website.